UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Abstract 11521: Circulating Thymosin Beta-4 is Elevated in Women With Heart Failure

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A11521-A11521

2016

Volltextzugriff (PDF)

Age prediction from human blood plasma using proteomic and small RNA data: a comparative analysis

Aging (Albany, NY.), 2023-06, Vol.15 (12), p.5240-5265

2023

Volltextzugriff (PDF)

Analysis of intact proteins from cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry after two-dimensional liquid-phase electrophoresis

Rapid communications in mass spectrometry, 1999-01, Vol.13 (24), p.2450-2455

1999

Volltextzugriff (PDF)

Both total and phosphorylated tau are increased in Alzheimer's disease

Journal of neurology, neurosurgery and psychiatry, 2001-05, Vol.70 (5), p.624-630

2001

Volltextzugriff (PDF)

Brain Magnetic Resonance Imaging Does Not Contribute to the Diagnosis of Chronic Neuroborreliosis

Acta radiologica (1987), 2007-09, Vol.48 (7), p.755-762

2007

Volltextzugriff (PDF)

The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids

Amyloid, 2001, Vol.8 (1), p.1-10

2001

Volltextzugriff (PDF)

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer’s disease

Neurochemistry international, 2004-07, Vol.45 (1), p.57-62

2004

Volltextzugriff (PDF)

The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process

Dementia and geriatric cognitive disorders, 2001-07, Vol.12 (4), p.257

2001

Volltextzugriff (PDF)

Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

Acta neurologica Scandinavica. Supplementum, 2003, Vol.179, p.47-51

2003

Volltextzugriff (PDF)

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Mild Cognitive Impairment

Acta neurologica Scandinavica. Supplementum, 2003, Vol.107 (179), p.47-51

2003

Volltextzugriff (PDF)

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Longitudinal studies on CSF biochemistry in MCI

Acta neurologica Scandinavica, 2003-02, Vol.107, p.47-51

2003

Volltextzugriff (PDF)

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

Acta neurologica Scandinavica, 2003-02, Vol.107 (s179), p.47-51

2003

Volltextzugriff (PDF)

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease

Archives of neurology (Chicago), 1999-06, Vol.56 (6), p.673

1999

Volltextzugriff (PDF)

Cerebrospinal fluid τ and β-amyloid (1-42) in dementia disorders

Mechanisms of ageing and development, 2001-11, Vol.122 (16), p.2005-2011

2001

Volltextzugriff (PDF)

Characterization of Proteins from Human Cerebrospinal Fluid by a Combination of Preparative Two-Dimensional Liquid-Phase Electrophoresis and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

Analytical chemistry (Washington), 1999-02, Vol.71 (3), p.642-647

1999

Volltextzugriff (PDF)

Clinical mass spectrometry in neuroscience. Proteomics and peptidomics

Cellular and molecular biology (Noisy-le-Grand, France), 2003-07, Vol.49 (5), p.681

2003

Volltextzugriff (PDF)

Clusterin in cerebrospinal fluid: Analysis of carbohydrates and quantification of native and glycosylated forms

Neurochemistry international, 2006-06, Vol.48 (8), p.718-728

2006

Volltextzugriff (PDF)

Combined solar and membrane drying technologies for sustainable fruit preservation in low-income countries – prototype development, modelling, and testing

Solar Energy Advances, 2021, Vol.1, p.100006, Article 100006

2021

Volltextzugriff (PDF)

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

Journal of neuroscience research, 2003-02, Vol.71 (4), p.526-533

2003

Volltextzugriff (PDF)

Comparative proteome analysis of thalamus in MK-801-treated rats

Proteomics (Weinheim), 2004-03, Vol.4 (3), p.819-825

2004

Volltextzugriff (PDF)

Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples

Proteomics (Weinheim), 2005-01, Vol.5 (1), p.307-317

2005

Volltextzugriff (PDF)

Comparison of Preparative and Analytical Two-Dimensional Electrophoresis for Isolation and Matrix-Assisted Laser Desorption/Ionization–Time-of-Flight Mass Spectrometric Analysis of Transthyretin in Cerebrospinal Fluid

Analytical biochemistry, 2002-02, Vol.301 (2), p.161-167

2002

Volltextzugriff (PDF)

Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques

Biochemical and biophysical research communications, 2010-10, Vol.401 (4), p.574-580

2010

Volltextzugriff (PDF)

Contribución de la apolipoproteína CIII a la aterogenicidad de las dislipidemias

Clínica e investigación en arteriosclerosis, 2012-09, Vol.24 (5), p.252-260

2012

Volltextzugriff (PDF)

CSF Markers for Early Alzheimer's Disease

Alzheimer's Disease, 2001, p.275-283

2001

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(104)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(73)
Humans
(67)
Biological And Medical Sciences
(37)
Aged
(34)
Cerebrospinal Fluid
(34)
Male
(33)
Medicin Och Hälsovetenskap
(32)
Female
(31)
Biochemistry & Molecular Biology
(29)
Medical Sciences
(29)
Neurosciences & Neurology
(29)
Neurology
(27)
Middle Aged
(24)
Alzheimer's Disease
(22)
Neurosciences
(22)
Mass Spectrometry
(21)
Alzheimer Disease - Cerebrospinal Fluid
(20)
Proteomics
(18)
Aged, 80 And Over
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 11521: Circulating Thymosin Beta-4 is Elevated in Women With Heart Failure

Age prediction from human blood plasma using proteomic and small RNA data: a comparative analysis

Analysis of intact proteins from cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry after two-dimensional liquid-phase electrophoresis

Both total and phosphorylated tau are increased in Alzheimer's disease

Brain Magnetic Resonance Imaging Does Not Contribute to the Diagnosis of Chronic Neuroborreliosis

The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer’s disease

The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process

Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Mild Cognitive Impairment

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Longitudinal studies on CSF biochemistry in MCI

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease

Cerebrospinal fluid τ and β-amyloid (1-42) in dementia disorders

Characterization of Proteins from Human Cerebrospinal Fluid by a Combination of Preparative Two-Dimensional Liquid-Phase Electrophoresis and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

Clinical mass spectrometry in neuroscience. Proteomics and peptidomics

Clusterin in cerebrospinal fluid: Analysis of carbohydrates and quantification of native and glycosylated forms

Combined solar and membrane drying technologies for sustainable fruit preservation in low-income countries – prototype development, modelling, and testing

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

Comparative proteome analysis of thalamus in MK-801-treated rats

Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples

Comparison of Preparative and Analytical Two-Dimensional Electrophoresis for Isolation and Matrix-Assisted Laser Desorption/Ionization–Time-of-Flight Mass Spectrometric Analysis of Transthyretin in Cerebrospinal Fluid

Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques

Contribución de la apolipoproteína CIII a la aterogenicidad de las dislipidemias

CSF Markers for Early Alzheimer's Disease

Suchergebnisse filtern